[A regimen consisting of cytarabine (Ara-C), mitoxantrone and etoposide, used as an induction treatment for pediatric acute myeloid leukemia (AML). ( NCI )]
UMLS (NCI) C0765500Mitoxantrone-AraC-Etoposide Regimen
Mitoxantrone-Cytarabine-Etoposide Regimen
MRC AML10 Study-MAE Regimen
- Therapeutic or Preventive Procedure